Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,655 | 468 | 92.4% |
| Education | $469.93 | 6 | 4.1% |
| Gift | $229.74 | 1 | 2.0% |
| Consulting Fee | $180.00 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,722 | 90 | $0 (2024) |
| PFIZER INC. | $680.08 | 41 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $667.68 | 32 | $0 (2024) |
| Boston Scientific Corporation | $567.52 | 13 | $0 (2024) |
| Teleflex LLC | $556.25 | 22 | $0 (2024) |
| Avadel Specialty Pharmaceuticals, LLC | $530.10 | 11 | $0 (2018) |
| Antares Pharma, Inc. | $481.87 | 16 | $0 (2024) |
| NeoTract Inc. | $462.26 | 13 | $0 (2020) |
| Janssen Biotech, Inc. | $429.14 | 20 | $0 (2024) |
| ABBVIE INC. | $425.26 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,805 | 77 | Teleflex LLC ($184.50) |
| 2023 | $1,225 | 53 | Astellas Pharma US Inc ($230.69) |
| 2022 | $1,716 | 64 | Antares Pharma, Inc. ($264.57) |
| 2021 | $1,270 | 54 | Astellas Pharma US Inc ($334.43) |
| 2020 | $649.95 | 33 | Astellas Pharma US Inc ($126.81) |
| 2019 | $989.60 | 46 | Astellas Pharma US Inc ($265.51) |
| 2018 | $1,842 | 73 | Avadel Specialty Pharmaceuticals, LLC ($530.10) |
| 2017 | $2,037 | 76 | NxThera, Inc. ($274.55) |
All Payment Transactions
476 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/13/2024 | ABC Home Medical Supply, Inc. | — | Food and Beverage | In-kind items and services | $25.07 | General |
| 12/12/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $21.53 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $1.85 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $29.71 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 11/28/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/21/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: Oncology | ||||||
| 11/18/2024 | 180 Medical, Inc. | GENTLECATH (Device) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: CONTINENCE CARE | ||||||
| 11/13/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/05/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $23.04 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $1.54 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: Urology | ||||||
| 10/22/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Oncology | ||||||
| 10/21/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/15/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: ONCOLOGY | ||||||
| 10/04/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $26.49 | General |
| Category: UROLOGY | ||||||
| 10/01/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $33.29 | General |
| Category: Urology | ||||||
| 09/24/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 3,237 | 9,322 | $1.2M | $334,429 |
| 2022 | 29 | 3,021 | 6,181 | $1.2M | $317,136 |
| 2021 | 23 | 2,412 | 5,724 | $948,621 | $239,671 |
| 2020 | 25 | 2,586 | 4,085 | $1.0M | $225,960 |
All Medicare Procedures & Services
108 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 674 | 1,098 | $384,300 | $104,457 | 27.2% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 96 | 2,171 | $184,535 | $74,657 | 40.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 116 | 148 | $107,300 | $28,136 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 232 | 332 | $81,340 | $22,563 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 162 | 162 | $77,580 | $20,706 | 26.7% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 11 | 105 | $78,750 | $14,097 | 17.9% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 145 | 275 | $68,950 | $13,861 | 20.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 125 | $10,625 | $6,170 | 58.1% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 96 | 167 | $14,195 | $5,743 | 40.5% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 96 | 167 | $14,195 | $5,743 | 40.5% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 12 | 2,101 | $21,010 | $4,778 | 22.7% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 22 | 69 | $12,075 | $4,747 | 39.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 336 | 468 | $23,400 | $4,012 | 17.1% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 26 | 79 | $23,700 | $3,912 | 16.5% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 12 | 43 | $19,350 | $3,179 | 16.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 747 | 1,280 | $25,600 | $2,816 | 11.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 115 | 132 | $13,200 | $2,361 | 17.9% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 11 | 11 | $8,800 | $2,162 | 24.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 18 | $6,750 | $1,840 | 27.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $5,400 | $1,484 | 27.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 11 | 19 | $5,020 | $1,291 | 25.7% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 18 | 22 | $6,358 | $1,281 | 20.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 33 | $2,805 | $1,221 | 43.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 128 | 142 | $3,550 | $1,184 | 33.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $2,100 | $615.16 | 29.3% |
About Dr. Padraic Mccahill, M.D
Dr. Padraic Mccahill, M.D is a Urology healthcare provider based in North Easton, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730186693.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Padraic Mccahill, M.D has received a total of $11,535 in payments from pharmaceutical and medical device companies, with $1,805 received in 2024. These payments were reported across 476 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($10,655).
As a Medicare-enrolled provider, Mccahill has provided services to 11,256 Medicare beneficiaries, totaling 25,312 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 108 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location North Easton, MA
- Active Since 07/06/2005
- Last Updated 05/23/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1730186693
Products in Payments
- XTANDI (Drug) $1,127
- XIAFLEX (Biological) $599.90
- Noctiva (Drug) $530.10
- ELIGARD (Drug) $419.16
- GEMTESA (Drug) $361.29
- MYRBETRIQ (Drug) $353.52
- UROLIFT (Device) $341.87
- Xtandi (Drug) $335.87
- UroLift (Device) $296.76
- Rezum (Device) $274.55
- NOCDURNA (Drug) $273.77
- PROVENGE (Drug) $262.54
- Myrbetriq (Drug) $255.91
- UroLift System (Device) $202.51
- ORGOVYX (Drug) $198.46
- JELMYTO (Drug) $191.39
- GENERAL - KIDNEY STONE DISEASE (Device) $188.21
- Erleada (Drug) $179.08
- XYOSTED (Drug) $169.15
- Urolift - UL400 (Device) $165.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in North Easton
Dr. James Fitzgerald, M.d, M.D
Urology — Payments: $19,246
Ryan Frankel, M.d, M.D
Urology — Payments: $12,798
Dr. Natalya Lopushnyan, Md, MD
Urology — Payments: $11,918
Jonathan Brajtbord
Urology — Payments: $7,184
Richard Mcardle, M.d, M.D
Urology — Payments: $158.32